Arrowhead Pharmaceuticals Inc. (ARWR) Tops Q1 EPS by 10c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. WDAY
2. NVDA
3. JNJ
4. META
5. AAPL
6. AMAT
7. SPY
8. ASML
9. NRIX
10. SUNS

Go back to Arrowhead Pharmaceuticals Inc. (ARWR) Tops Q1 EPS by 10c

Arrowhead Pharmaceuticals Reports Fiscal 2026 First Quarter Results

February 5, 2026 4:05 PM EST

- Conference Call and Webcast Today, February 5, 2026, at 4:30 p.m. ET

PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2026 first quarter ended December 31, 2025. The Company is hosting a conference call today, February 5, 2026, at 4:30 p.m. ET to discuss the results.

We had another quarter of strong execution across all areas of our business and we think Arrowhead is extremely well positioned to build on this progress throughout 2026 and beyond, said Christopher Anzalone, Ph.D., President and CEO at... More